MedCap AB MCAP
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- SEK 421.50
- Day Range
- SEK 422.00–433.00
- 52-Week Range
- SEK 246.00–433.00
- Bid/Ask
- SEK 430.00 / SEK 432.00
- Market Cap
- SEK 6.40 Bil
- Volume/Avg
- 14,000 / 13,898
Key Statistics
- Price/Earnings (Normalized)
- 39.60
- Price/Sales
- 3.94
- Dividend Yield (Trailing)
- —
- Dividend Yield (Forward)
- —
- Total Yield
- —
Company Profile
MedCap AB acquires and develops profitable, market-leading niche companies in the Nordic life science industry. It is diversified into two business areas namely Medical technology and Specialist medicines. Medical Technology mainly develops and sells various medical technology products and services. Its Specialist medicines develop and sell medicines within the regulatory classes of registered, extemporaneous and licensed medicines.
- Sector
- Healthcare
- Industry
- Medical Devices
- Stock Style Box
- Small Growth
- Total Number of Employees
- 476
- Website
- https://www.medcap.se
Comparables
Valuation
|
Metric
|
MCAP
|
LINC
|
BICO
|
|---|---|---|---|
Price/Earnings (Normalized) | 39.60 | 9.13 | — |
Price/Book Value | 6.10 | 1.06 | 0.66 |
Price/Sales | 3.94 | 1,045.57 | 1.48 |
Price/Cash Flow | 21.06 | — | — |
Price/Earnings
MCAP
LINC
BICO
Financial Strength
|
Metric
|
MCAP
|
LINC
|
BICO
|
|---|---|---|---|
Quick Ratio | 1.35 | 282.70 | 1.76 |
Current Ratio | 2.23 | 282.69 | 2.41 |
Interest Coverage | 14.80 | — | −16.51 |
Quick Ratio
MCAP
LINC
BICO
Profitability
|
Metric
|
MCAP
|
LINC
|
BICO
|
|---|---|---|---|
Return on Assets (Normalized) | 10.75% | 0.20% | −4.22% |
Return on Equity (Normalized) | 17.72% | 0.20% | −6.38% |
Return on Invested Capital (Normalized) | 13.91% | −0.32% | −4.08% |
Return on Assets
MCAP
LINC
BICO
Medical Devices Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|
ABT
| Abbott Laboratories | Jdtkddn | Xxnsdy | $185.4 Bil | |
SYK
| Stryker Corp | Lbrgstltr | Fqwh | $127.7 Bil | |
MDT
| Medtronic PLC | Nvnkgrs | Pcdwvrh | $107.4 Bil | |
BSX
| Boston Scientific Corp | Jymvsvym | Kzljwmm | $106.6 Bil | |
DXCM
| DexCom Inc | Zszgfdqhqf | Rgtj | $54.7 Bil | |
EW
| Edwards Lifesciences Corp | Qbcnhkzn | Dnrvgt | $51.8 Bil | |
ZBH
| Zimmer Biomet Holdings Inc | Mgzlpsctls | Rznt | $25.0 Bil | |
ALGN
| Align Technology Inc | Xykstbg | Nylzbq | $23.4 Bil | |
PHG
| Koninklijke Philips NV ADR | Nrscwrk | Pwjvnss | $19.2 Bil | |
PODD
| Insulet Corp | Rfftkwjm | Jgqnr | $11.9 Bil |